Abstract | BACKGROUND/AIMS: METHODS: miR-203 expression was detected in cervical cancer tumors and cell lines by qRT-PCR. The methylation status in the promoter region of miR-203 was examined by methylation-specific PCR. The functional effect of miR-203 was determined by both in vitro and in vivo assays. RESULTS: miR-203 was frequently down-regulated in cervical cancer tumors and cell lines. This down-regulation of miR-203 was associated with methylation of the miR-203 promoter. Furthermore, miR-203 down-regulated vascular endothelial growth factor alpha (VEGFA) expression by directly targeting its 3'-untranslated region. Functional assays revealed that miR-203 suppressed cervical cancer cell proliferation, tumor growth, and angiogenesis in nude mice, whereas forced expression of VEGFA rescued this inhibitory effect. CONCLUSION: Our collective findings indicate that miR-203 functions as a tumor suppressor by targeting VEGFA, resulting in the inhibition of tumor growth and angiogenesis. Thus, miR-203 may be a potential therapeutic target and prognostic marker in cervical cancer.
|
Authors | Xiangyu Zhu, Kejun Er, Caiying Mao, Qi Yan, Haijun Xu, Yuanbei Zhang, Jianhong Zhu, Fang Cui, Wenxia Zhao, Hong Shi |
Journal | Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
(Cell Physiol Biochem)
Vol. 32
Issue 1
Pg. 64-73
( 2013)
ISSN: 1421-9778 [Electronic] Germany |
PMID | 23867971
(Publication Type: Journal Article)
|
Copyright | Copyright © 2013 S. Karger AG, Basel. |
Chemical References |
- 3' Untranslated Regions
- MIRN203 microRNA, human
- MicroRNAs
- VEGFA protein, human
- Vascular Endothelial Growth Factor A
|
Topics |
- 3' Untranslated Regions
- Animals
- Base Sequence
- Cell Line, Tumor
- Cell Proliferation
- DNA Methylation
- Down-Regulation
- Female
- HeLa Cells
- Humans
- Mice
- Mice, Nude
- MicroRNAs
(genetics, metabolism)
- Neovascularization, Pathologic
- Promoter Regions, Genetic
- Transplantation, Heterologous
- Uterine Cervical Neoplasms
(genetics, metabolism, pathology)
- Vascular Endothelial Growth Factor A
(antagonists & inhibitors, genetics, metabolism)
|